BSE filing, NSE: BANSISONS. Summary written from the filing by ALFA Finder's alert engine.
Novyra Pharmachem Ltd: key numbers
- Share price
- ₹8.08
- Market cap
- ₹5.11 Cr
- Revenue (annual)
- ₹0.10 Cr
- Net profit (annual)
- ₹-5.37 Cr
- P/E (TTM)
- -0.9×Sector 26.2×
- Promoter holding
- 23.15%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Novyra Pharmachem Ltd
All →Novyra Pharmachem Board Meeting Date
Novyra Pharmachem will hold a board meeting on 2 November 2026 to consider unaudited Q2 results. Agenda items remain proposed until the meeting.
Novyra Pharmachem Other Announcement
Novyra Pharmachem Ltd filed its quarterly shareholding pattern as per SEBI Regulation 31(1)(b) for the quarter ended September 30, 2026.
Bansisons Tea Industries Other Announcement
The company has officially changed its name from Bansisons Tea Industries Limited to Novyra Pharmachem Limited. This change reflects the company's expansion into the pharmaceutical sector.
Bansisons Tea Industries Q1 FY27 Results: Net Profit ₹0 Cr
Bansisons Tea Industries Ltd reported revenue from operations of ₹1.7 Cr and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Bansisons Tea Industries Board Meeting Date
Novyra Pharmachem Limited has scheduled a board meeting for August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Bansisons Tea Industries Other Announcement
Novyra Pharmachem Limited has updated its official website address. The change is being intimated to the exchange for record-keeping purposes.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.